Gliclazide Market size was valued at USD 1.5 Billion in 2024 and is forecasted to grow at a CAGR of 6% from 2026 to 2033, reaching USD 2.5 Billion by 2033.
South Korea's Gliclazide Market: Industry Demands and Market Dynamics
The Gliclazide Market in South Korea is experiencing notable growth, driven by the increasing prevalence of type 2 diabetes and the aging population. Gliclazide, a second-generation sulfonylurea, is widely used for its efficacy in controlling blood glucose levels in type 2 diabetic patients.
In 2023, the global Gliclazide Market was valued at approximately USD 1,039.2 million and is projected to reach USD 1,744.3 million by 2031, growing at a CAGR of 3.6% during the forecast period. South Korea contributes significantly to this growth, with a high demand for oral anti-diabetic drugs, including Gliclazide.
Key factors influencing the market include:
Regulatory Environment: The Ministry of Food and Drug Safety (MFDS) in South Korea mandates a comprehensive Drug Master File (KDMF) for Gliclazide, ensuring the safety and efficacy of the drug.
Manufacturing Standards: Manufacturers are required to adhere to Good Manufacturing Practices (GMP), with certifications like the Written Confirmation (WC) being essential for export and domestic distribution.
Market Segmentation: Gliclazide is available in immediate-release and extended-release formulations, catering to diverse patient needs and improving compliance.
Distribution Channels: The drug is distributed through hospital pharmacies, retail pharmacies, and online platforms, enhancing accessibility for patients.
Industrial requirements emphasize the need for high-purity Gliclazide, with manufacturers focusing on achieving purity levels exceeding 99% to meet stringent quality standards. The demand for generic formulations is also rising, driven by government initiatives to reduce healthcare costs and improve drug accessibility.
In summary, the Gliclazide Market in South Korea is poised for sustained growth, supported by regulatory frameworks, manufacturing excellence, and a focus on meeting the evolving needs of the diabetic population.
Get an In-Depth Research Analysis of the South Korea Gliclazide Market Size And Forecast [2025-2032]
Discovery Fine Chemicals
CarboMer
HBCChem
Ivy Fine Chemicals
Clearsynth
Bal Pharma
Fengchen Group
Sinopharm
Hairuichem
Dayang chem
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Gliclazide Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Gliclazide Market
Immediate-release Tablets
Extended-release Tablets
Oral Suspension
80 mg
30 mg
60 mg
Other dosages (custom formulations)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Age Group
Gender
Type 2 Diabetes Mellitus
Polycystic Ovary Syndrome (PCOS)
Other Metabolic Disorders
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Gliclazide Market Research Analysis
1. Introduction of the South Korea Gliclazide Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Gliclazide Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Gliclazide Market, By Type
6. South Korea Gliclazide Market, By Application
7. South Korea Gliclazide Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Gliclazide Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/